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Introduction 
 
Leukemia is an aggressive blood cancer, predominately diagnosed 
in children. It occurs when one lymphoblast, an immature white blood 
cell, turns malignant, multiplying uncontrollably and spreading 
rapidly throughout the body. If left untreated, the disease can be fatal 
in a few weeks. Unregulated proliferation of lymphoblasts is 
associated with deregulation of cell division and differentiation 
pathways. One of the key pathways involved in the regulation of cell 
differentiation and proliferation is the Notch signaling pathway and 
deregulation of the genes in this pathway may lead to uncontrolled 
proliferation observed in cancers such as Leukemias. Cancer related 
events are not just one gene signaling/defects, but multiple events 
which turn on the cells in synchrony to produce tumors, like clonal 
expansion. Therefore our intention was to understand the signaling 
network of Notch gene to understand how it promotes 
leukemogenesis which is not known until now.  
The Notch signaling pathway, first described in Drosophila and 
Caenorhabditis elegans, is involved in the regulation of many 
developmental cell fate decisions. In Drosophilia, Notch interaction 
with its cell-bound ligands, Delta and Serrate, initiates an intercellular 
signaling pathway which plays a central role in development. In 
humans though homologues of the Notch-ligands have been 
identified, precise interactions and interplay between the ligands and 
the Notch homologues remain to be determined [2]. 
 
 
 
 
 
 
 
 
 
  
 
Mammalian Notch was first identified in 1991 in a translocation 
that brought the Notch1 gene under the transcriptional control of the 
T-cell receptor β locus in a T-cell acute lymphoblastic leukemia [3]. 
The role of Notch in T-ALL was elucidated by Weng et al. [4], who 
demonstrated that over 60% of human T-ALL patients carried 
activating mutations in the Notch1 gene. This observation led to 
further studies regarding the role of Notch in leukemia development. 
A report by Rosati et al. [5] implicated Notch1 and Notch2 signaling 
in B-cell chronic lymphocytic leukemia (B-CLL) and suggested a 
different mechanism for Notch activation than that observed by 
Weng et al. [4]. Yet, a clear understanding of the specific Notch 
receptors and ligands involved in this process, and the mechanisms of 
Notch action, are still lacking. Based on the various observations of 
Notch signaling pathway we decided to find out the players in notch 
signaling pathway. Hence the aim of our study was to construct a 
protein interaction network with Notch1protein as the query protein. 
 
Methods, Databases /Software 
 
To decipher the associated protein interactors with Notch1 we 
designed a protocol, as described here, to record the observed 
interaction with other molecules which can help decipher which 
interactions could be associated with proliferative mechanisms. 
Further, we tried to assess the importance of the most highly 
connected proteins from this study by analyzing their clusters using 
bioinformatics database STRING [6] which was used to construct 
and retrieve protein interaction network. This database derives a high-
throughput experimental data from a wide range of sources and 
analyses the co-expression of genes computationally and uses a scoring 
framework and outputs a single confidence score per prediction. This 
confidence score is a measure of reliability of the predicted 
interactions and a high score indicates that the predicted interactions 
are also replicated in KEGG database. Thus, we retrieved the Notch1 
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protein interaction network with a high confidence score from the 
STRING database and we analyzed the network to predict novel 
genes which may contribute to leukemogenesis. 
 
To infer the interactions of NOTCH1 with other proteins, we 
used STRING database v9.  STRING (Search Tool for the Retrieval 
of Interacting Genes, available at : http://string-db.org/  [6]) is a 
database of functional associations that have been pre-computed and 
derived from a wide range of sources such as high-throughput 
experimental data, literature and database mining, analyses of co-
expressed genes and computational predictions. The database 
interactions are based on a scoring framework and the output 
interactions have a single confidence score per prediction. For our 
study, we queried the database using NOTCH1 as protein query 
name and selected the interactions available for Homo sapiens. We 
grew the interaction network to obtain 201 protein interactors. The 
database further allows the user to delineate interactions based on 
three levels of confidence scores- low (0.4 which represents 20%), 
medium (0.7 more than 50%) and high (0.9 greater than 75%). This 
score indicates the probability that a link predicted between two 
proteins is replicated in the KEGG database. To refine the quality of 
the NOTCH1 network, we selected only those interactions to be 
displayed that have a confidence score greater than 0.9 which 
indicates that the predicted network is highly reliable. 
A better understanding of the network proteins and their 
interactions was obtained by grouping molecules which share some 
degree of similarity in terms of functional association. STRING 
database allows the user the choice of two clustering algorithms- 
MCL (Markov clustering) and k-Means Clustering. Further, the 
database allows the user  to define the number of clusters. In the 
current study, we applied k-means clustering algorithm [7] as it is 
computationally fast, which is based on Adjacency matrix and 
delineates data into pre-defined number of clusters. We specified the 
number of clusters to be 10 based on the rule of thumb k= (n/2), 
where n is number of nodes (protein interactors) in the cluster. The 
resulting clusters were separated manually for better visual 
representation and understanding. 
 
Enrichment analysis for the protein interactors in this network 
was performed using WebGestalt, WEB-based GEne SeT AnaLysis 
Toolkit (available at http://bioinfo.vanderbilt.edu/webgestalt/) [8], 
which is a data mining system that allows the user to explore and 
visualize biological information related to the data set. The protein 
interactors list was loaded onto the interface and analysis was 
performed with reference set selected as human genome. A 
Hypergeometric test was used to evaluate the statistical significance of 
the enrichment analysis.  Benjamin and Hochberg method was used as 
the model for multiple test adjustment to check false discoveries. A P-
value of 0.05 and a minimum of two genes per category were used as 
a cut-off to obtain significant enrichments.   
 
The Notch1protein-protein interaction network   was 
downloaded as an xml file from STRING database which contains 
data in Protein Standards Initiative (PSI) format. This file was 
imported into Cytoscape software [9] which is an open source 
Network visualization software with additional plugins for analysis of 
the network data. The Notch1 network was analyzed using Network 
Analyzer plugin [10] to obtain the topological properties of the 
interaction network.  The topological properties include node degree 
distribution, average clustering coefficient, diameter, path length [11]. 
In a biological network, a node is any biological molecule and an edge 
indicates the interaction between two nodes. 
 
Degree distribution: The degree of a node in a biological network 
is the number of interactions it forms. The degree distribution P(k) 
indicates the probability that a given node has exactly k interactions. 
For scale free networks the degree distribution follows power law i.e 
P(k)~k-γ, wherein γ is the degree exponent [11].   
Characteristic path length: The characteristic path length is the 
expected distance between two nodes [11]. 
Diameter: The diameter of the network is the maximum of the 
shortest distance between two nodes [11]. 
Clustering coefficient: Clustering coefficient indicates the 
propensity of nodes to cluster to form groups [11].   
 
Further, to assess which genes in the network form hubs, 
cytoHubba plugin [12] was utilized with confidence value set to edge 
attribute and the ranking methods included degree and betweenness. 
Hubs are nodes with the highest number of interactions. The degree 
method was chosen as it indicates the importance of a particular node 
on the network. Betweenness centrality is a measure of influence of a 
particular node on the flow of information in the network [13, 14]. 
The cut off value for the top nodes was 50 proteins. The resulting list 
of 50 proteins from degree ranking method and 50 proteins from 
betweenness ranking method were compared and the proteins 
common to both lists (degree and betweenness) were utilized for 
further analysis. These common proteins were selected since they 
occur in both hub lists and hence may be more significant for analysis.  
 
In order to assess the importance of these genes in Acute 
Lymphoblastic Leukemia, we analyzed the difference in the expression 
levels of the genes encoding these proteins in leukemic cells when 
compared to normal cells. Oncomine database is a comprehensive 
cancer microarray expression database wherein the expression data 
from the various studies are log-transformed and median-centered for 
each array [15]. The database allows the user to perform various 
analyses, in the form of filters, on the deposited expression data based 
on the user requirement.  For the current study, the primary filters 
Cancer Type and Analysis Type were used to retrieve only those 
studies pertaining to T-cell Acute Lymphoblastic Leukemia wherein 
the database performed a differential analysis of the expression level 
of the genes in normal state vs. disease state. This showed two 
relevant datasets, Andersson et al. [16] and Haferlach et al. [17].  
Each of the common hub genes was queried to assess their expression 
levels in these two studies. The database assigns a gene rank to each 
gene which pertains to the rank of that gene in a particular dataset 
based on its p-value. The p-value is calculated by the database based 
on Student’s t-test statistic and indicates difference between the 
groups specified for differential analysis.  The presence of the gene in 
both studies and the gene rank were used as parameters to assess the 
significance of the genes in T-cell Acute Lymphoblastic Leukemia. 
 
Results 
The biological network derived from STRING database using 
Notch1 as query was observed to be a dense network comprising 201 
interacting proteins.  The most highly connected protein interactions 
seemed to be situated at the centre while Notch1 and its interacting 
proteins were observed to be located at the periphery. A few of the 
other protein interactors were also located at the periphery (Figure 1).  
Notch Interaction Network 
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The gene ontology (GO) enrichment analysis results were 
represented in the form of a directed acyclic graph with the most 
significant terms highlighted in red. The biological process GO graph 
is shown in Supplementary Figure S1. Some of the important 
biological processes in which the genes encoding these proteins 
participate include signaling pathways such as Wnt and Notch, 
regulation of cell differentiation, cell fate commitment and regulation 
of metabolic processes. KEGG Pathway enrichment analysis revealed 
the proteins were involved in many pathways, important among them 
being Notch, TGF-beta, ErbB, MAPK, Jak- STAT, Wnt, T cell 
receptor and B cell receptor pathways.  Some of the important 
pathways are shown in Table 1. 
Figure 1. Notch1 Protein-Protein Interaction Network 
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To infer a better understanding of the interactions, the network 
was divided into ten clusters using k-means clustering option provided 
by the STRING database (Figure 2). The clusters were composed of 
densely connected protein interactors, mostly sharing either similarity 
in function or occurrence in the same pathway. Many of the 
interacting proteins were also connected with molecules in other 
clusters, probably indicating that they share functional associations 
with the other clusters, which might also represent that these 
molecules play key roles in several diverse pathways. 
Figure 2. Notch 1 PPI network differentiated into 10 k-means clusters 
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Cluster 1 contains proteins such as cadherins and cadherin 
associated proteins that are active in the process of cell adhesion. The 
biggest cluster, cluster 2, was centered around CTNNB1 molecule 
and contains proteins with diverse functions such as regulation of cell 
adhesion, Wnt signaling, cell proliferation, essential cell cycle proteins 
like CCND1,CCND2 and growth factors. 
The protein interactors in cluster 3 are key participants of the 
Wnt signaling process. Wnt signaling has been reported to play an 
essential role in the hematopoietic development process.  The fourth 
cluster is made of proteins that are important to TGF-beta mediated 
signaling process. This signaling is involved in processes such as 
proliferation, apoptosis, differentiation and migration, which are 
necessary for normal growth and development of an organism. 
Some of the proteins in cluster 5 such as DLL1, DNER, and 
PSEN1 are important in Notch mediated signaling pathway. The 
other proteins involved in this process were adhesion proteins 
transport proteins and some others that were associated with gamma 
secretase complex. 
The Notch1 cluster, which forms the seventh cluster, is a tightly 
connected cluster of 32 molecules. This cluster included molecules 
that were a common part of the Notch signaling network such as 
Notch binding ligands JAG1, JAG2, DLL3; activators of Notch 
pathway such as ADAM17; FBXW7 which are involved in the 
degradation of intracellular Notch; transcriptional coactivators of 
Notch such as MAML1-3; downstream effector of Notch signaling 
such as HEY1; targets such as HES1 and HES5 and transcriptional 
regulators such as IKZF1.  
The molecules in the above cluster seem to be highly connected to 
cluster 6, which comprises proteins such as RBPJ (an important 
mediator of Notch signaling), Notch 2 and 3, DLL4 that are also 
integral parts of the Notch signaling pathway. 
The protein interactors of cluster 8 are involved in functions such 
as cell migration, protein transport and cell growth and development.  
Cluster 9 had fewer proteins of the PI3K- PI3K–PTEN signaling 
network pathway such as PIK3R1, AKT and the FOXO family of 
proteins. MDM2 and NFKB1 proteins are also part of this cluster. 
Most of the proteins in this cluster are involved in regulation of 
apoptotic mechanisms. MDM2 is an essential regulator of p53, and 
plays a vital role in p53 mediated apoptosis. NFKB1 plays an 
important role in various processes including cell differentiation, cell 
growth and apoptosis processes. Hence, the molecules in this cluster 
are crucial for the proper functioning of the cell cycle process and for 
differentiation.  
Cluster 10 is composed of transcriptional regulators such as 
MYC, EP300, JUN, KAT2B that act as activators and transcription 
factors and are essential for the proper expression of several genes. 
 
Analysis of the Network revealed that the Notch1 protein 
interaction network is a small world scale free network which follows 
power law (P(k)~ k-γ) of node degree distribution with a degree 
exponent of 0.856 and R2 of 0.737, where R2 indicates the fitness of 
data points to the curve. The characteristic path length was calculated 
by the software to be 2.342 and the network diameter was found by 
the software to be 4.The clustering coefficient, which is a measure of 
cluster forming ability of a particular node, was found to be 0.520 
[11]. 
 
 
 
The hub genes obtained from degree ranking method and 
betweenness method were compared to derive genes which are 
common to both and hence may play a role in the disease process. 
Forty two genes (Table 2) were observed to be common to both the 
degree and betweenness methods and this included the query 
molecule, Notch1.  The expression level of each of these genes when 
queried in Oncomine database revealed that some of these genes were 
significantly overexpressed in the T-ALL samples while some were 
underexpressed. Only those genes whose expression has been reported 
in both of the studies used for the analysis were considered 
significant. Oncomine calculates the gene rank of each gene based on 
its p-value for each study and this gene rank is an indicator of the 
significance  of  the  gene  in  a  particular study. We considered only  
Notch Interaction Network 
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those genes whose cumulative gene rank from both the analysis was in 
the top 36% of all the over- or under-expressed genes in the studies. 
This step was incorporated to ensure that the change in expression of 
the genes was significantly different in the leukemic cells when 
compared to their expression in normal cells.  The resultant gene list 
consisted of sixteen genes which were significantly underexpressed and 
eleven genes which were significantly overexpressed in relation to 
other genes in T-cell Acute Lymphoblastic cells in comparison to 
normal cells (Table 3). Most of the underexpressed genes are 
important tumor suppressors and/or play an essential role in the 
apoptotic process. The genes which are significantly overexpressed 
function in cell cycle progression, proliferation, cell survival, 
transcriptional regulation and development.  These genes were queried 
in earlier studies on ALL to determine if their role in leukemogenesis 
has been established. While many of the genes in this list have been 
reported earlier in association with ALL [4,18-28], some have not yet 
been studied in relation to the disease. These include the genes 
KAT2B, CDH2 and PSEN1 which have important biological 
significance in the hematopoiesis process due to their role in Notch 
signaling (KAT2B and PSEN1) and cell adhesion (CDH2) and their 
role in leukemogenesis has yet to be investigated.  Three other genes 
from our study - SMAD4, CTNNA1, RAC1-have been reported in 
earlier studies but their role in T-cell leukemogenesis has not yet been 
elucidated. 
 
Discussion 
 
The Notch family of genes, which in Mammals include the  four 
transmembrane Notch receptor homologs (Notch1,Notch2, Notch3, 
Notch4), plays a key role in regulating many developmental 
differentiation processes including hematopoiesis during 
embryogenesis, T cell lineage commitment and maturation  in the 
thymus and Marginal zone B cell development in the spleen [29]. The 
Notch signaling pathway involves many transcriptional regulatory 
processes [30]. These glycoprotein receptors consist of iterated 
Notch Interaction Network 
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structural motifs and an intracellular ankyrin-like repeat region that 
plays an important role in downstream signaling events. The Notch 
receptors bind to any of the five ligands, Delta-like 1, 3 and 4 and 
Jagged 1 and 2, which initiates the signaling pathway [31,32]. Ligand 
binding to Notch protein leads to proteolytic cleavage and release of 
Notch intracellular domain (NICD) fragment which is the key 
signaling component [33]. Notch proteins are 300kDa ligand-
activated heterodimeric receptors [1]. The Notch 1 gene is located on 
the long (q) arm of chromosome 9 at position 34.3 (Figure 3). 
 
 
 
 
 
 
The Notch homologs and their ligands have been reported to be 
expressed in bone marrow, fetal liver, thymus, stromal cells indicating 
that they play an important role in the hematopoietic process [34]. 
Notch1 consists of two key domains- PEST and the HD domains. 
Mutations in the PEST domain lead to deletion of this region, which 
normally regulates NICD degradation and hence leads to increased 
NOTCH1 activity. Mutations in the N- and C-terminal of the HD 
domain lead to ligand-independent Notch signaling.  Thus alterations 
in this gene and its protein product lead to severe implications in the 
biological processes in which it functions [35]. Mutation in Notch1 
has been implicated in the pathogenesis of Leukemias. These 
alterations also affect the Notch signaling network leading to 
uncontrolled proliferations and disruptive differentiation processes 
which are characteristic of leukemias. Also, the genes/proteins 
involved in Notch signaling and other interactors of Notch may 
contribute to increased severity of disease process through 
deregulation of other pathways in which they participate. Among the 
Leukemias, Notch1 deregulation is more commonly observed in T-
cell Acute Lymphoblastic Leukemia which may be due to the 
importance of Notch signaling pathway in T cell development and 
proliferation of committed T-lineage progenitor cells [36].  
Studies have reported that mutations in Notch1 prevent 
functioning of domains that are essential to prevent spontaneous 
activation of Notch. These mutations lead to increase in Notch 
signaling which in turn leads to deregulation of the signaling pathway.  
Mutations in FBXW7 also promote increase in Notch signaling by 
supporting the stability of activated Notch1 [37]. Palomero et al. 
[38] have reported that Notch and MYC regulate interconnected 
transcriptional pathways which involve many common genes and 
which help in regulation of cell growth in T-ALL leukemic cells.    
 
The Notch protein sits like a trigger spanning the cell membrane, 
with part of it inside and part outside. Ligand binding to the 
extracellular domain induces proteolytic cleavage with the release of 
the intracellular domain which enters the nucleus to alter gene 
expression [39] (Figure 4). 
The Notch cascade involves the transmission of Notch signal to 
the cell nucleus with the help of the various Notch proteins, their 
ligands and intracellular proteins. The Notch/Lin-12/Glp-1 receptor 
family has also been reported to be implicated in cell fate specification 
during development in Drosophila and C. elegans [1]. 
Palomero et al. [40] showed that, in rare cases of Acute Myeloid 
Leukemia (AML), activated mutation in Notch1 contributed to 
hindrance in granulocytic differentiation process and led to 
maintenance of myeloid cells in immature phenotypic state.  Other 
studies have implicated that alterations in the Notch ligand, 
JAGGED1, might contribute to the leukemogenesis process in AML 
[41]. A study by Chen et al. [42], in AML cells, reported that 
downregulation of Notch1 leads to a decrease in expression of 
PU.1/MCSFR, which leads to dysregulation in the myeloid cells.  
Notch signaling may also be involved in Chronic Myeloid Leukemia 
leukemogenesis through HES1, though this has not been 
experimentally validated [43].  Rosati et al. [5] suggest that Notch 
signaling plays a crucial role in survival and apoptosis resistance in B-
Chronic Lymphocytic Leukemia cells with the cells expressing 
Notch1 and 2 and Jagged 1 and 2 which are not usually found in 
normal B cells. These studies highlight the importance of Notch 
signaling in the leukemogenesis process. Notch signaling is involved 
in the regulation of stem cell self-renewal in several systems. Meta 
analysis of genes and proteins helps provide insight into key processes 
regulating neoplastic and other dysregulated processes and also help in 
determination of therapeutic targets and development of therapeutic 
moieties as demonstrated through our previous studies [44-54].  
In our study we present a different picture of Notch interacting 
players. We have observed that, of the clusters obtained, three clusters 
seem to be involved in mechanisms leading to neoplastic 
transformation. Two of the clusters are mainly involved in the Notch 
signaling network and hence alterations in the proteins in the cluster 
would affect differentiation and proliferation processes. The Notch 1 
protein is also associated with molecules in the ninth cluster, many of 
whose proteins are involved in the PI3K-PTENpathway. This cluster 
consists of proteins that play a crucial role in control of cellular 
proliferation. Alterations in the proteins of this cluster and also 
changes brought about in Notch1 or its signaling network could cause 
deregulation of the proliferation processes leading to increased and 
uncontrolled proliferative signals, defects in differentiation process 
and to a block in the apoptotic process. Notch signaling has also been 
reported to participate in antiapoptotic mechanisms through p53 and 
NFκB pathway [55-58]. Deregulation of these mechanisms leads to 
increased deterrence of apoptosis which in turn prevents elimination 
of leukemic/ neoplastic cells. 
The Notch1 cluster is also connected to cluster 4 through 
SMAD3, which along with the other proteins in this cluster, plays an 
important role in TGF-beta mediated signaling which helps in the 
regulation of cell cycle and apoptosis processes.  Alterations in 
Notch1 might affect expression of SMAD3, hindering the cell cycle 
process and resulting in uncontrolled proliferation. 
Many proteins in this network also participate in Wnt mediated 
regulation of hematopoietic development. Recent studies have 
reported that upregulation of this signaling pathway was observed in 
most of the Leukemias [59], highlighting the need to direct 
therapeutic approaches targeting this signaling pathway. 
In this study, we observed that the protein interactors associated 
with disease seem to cluster together and to interact closely with other 
clusters that might also be implicated in disease pathogenesis. This 
observation is similar to reports from other studies wherein proteins 
involved  in  a particular  disease  tend  to  form  a  closely  associated  
Figure 3. Chromosomal location of Notch1 gene 
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network [60]. We observed that proteins that play key roles in 
control of proliferation and differentiation are associated directly or 
indirectly with Notch1 or other molecules of the Notch signaling 
network. These associations might be indicative of interconnected 
pathways/ mechanisms whose deregulation and alterations might 
provide oncogenic signals.  Understanding the interactions between 
proteins and/or genes is crucial as studies on cancer metasignature 
genes have implied that proliferation of cancer may involve cancer 
related genes from numerous pathways [61]. Though the external 
triggers for the leukemogenic signals are not yet clearly understood, 
analysis of the molecular pathways through which these signals 
proceed might help in developing more effective therapeutic strategies 
and in identification of better prognostic markers. Notch proteins 
regulate a broad spectrum of cell fate decisions and differentiation 
processes during fetal and postnatal development. 
 
Our study analyzed the protein interaction network data to 
identify hub proteins. We identified 50 hub proteins, through degree 
and betweenness ranking methods, each of which had numerous 
interactions within the network. On analysis of the expression levels 
of the genes encoding the common hub proteins, we observed that the 
genes that were associated with regulation of apoptosis and that have 
crucial tumor suppressor functions were underexpressed, which is 
characteristic of Leukemia and other cancers. We also found that the 
genes involved in various biological processes such as cell cycle, 
proliferation and gene expression were overexpressed. Through this 
analysis, we have identified three proteins- KAT2B, PSEN1 and 
CDH2- which are important hub proteins and whose expression 
levels were deregulated in T-cell Leukemic samples in the studies by 
Andersson et al. [16] and Haferlach et al. [17].  
KAT2B is a transcriptional coactivator that plays a role in 
transcriptional regulation and inhibition of cell cycle progression. 
PSEN1 is involved in the proteolytic processing of membrane 
proteins such as Notch, TrkB, and APLP2 and whose expression has 
been reported in lymphocytes [62]. KAT2B and PSEN1, which were 
observed to be underexpressed, are important components of the 
Notch signaling network. Notch intracellular domain fragment 
(NICD) translocates to the nucleus and forms a complex with DNA 
binding protein CSL. This complex along with the help of co-
activators MAML and KAT2B leads to the transcriptional activation 
of Notch target genes [63]. Gamma secretase complex which 
comprises PSEN1 and 2, NCSTN, APH-1 and PEN-2 cleaves 
Notch molecule at its transmembrane domain to give rise to Notch 
intracellular Domain fragment (NICD) [64] which translocates to the 
nucleus and leads to activation and propagation of Notch signaling. 
CDH2 is a calcium dependent cell adhesion protein. Studies by 
Wilson et al. [65] have shown that maintenance of balance between 
self-renewal and differentiation of hematopoietic stem cells by c-Myc 
occurs in N-cadherin dependent manner, specifically c-Myc associated 
differentiation of Hematopoietic stem cells and their subsequent 
movement is associated with CDH2 downregulation. The 
overexpression of CDH2 observed in T-cell Leukemia samples 
analyzed in our study and its role as a hub protein indicates that this 
gene needs to be investigated further using experimental procedures to 
assess its significance in Leukemogenesis.  
In interaction networks, hubs are usually molecules that have the 
highest number of interactions in the network. Hub genes are thought 
to play crucial roles in cell processes and hence possess biological 
significance [66].  Several studies have been carried out to determine 
the importance of hub molecules in cellular processes and diseases.  
Batada et al. [67] have suggested that hub proteins play an essential 
role in rate of cell growth and are carefully regulated. Hub proteins 
have also been associated with high lethality in a study on yeast 
proteins [66]. Zotenko et al. [68] have proposed that hub proteins are 
essential as they are usually a part of a dense network of essential 
proteins which are needed to perform specific biological functions.   
Figure 4. KEGG Pathway database map showing Notch signaling including proteolytic cleavage and translocation of Notch followed by 
transcriptional activation of Notch target genes 
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Jonson and Bates [60] have reported that generally cancer-related 
proteins have more interactions than non-cancer proteins.  Goh et al. 
[69] report that though essential genes encode hub proteins, most of 
the disease genes are non-essential and are do not encode hub 
proteins. Though there are varied views regarding the significance of 
hub molecules in disease almost all the studies agree that genes that 
encode hub proteins have biological significance.  
Expression of some of the other genes such as SMAD4 [18], 
CTNNA1 [19], RAC1 [20] has been reported but their contribution 
to the leukemogenesis process has not been clearly understood.  
In the expression datasets analyzed, NFKB1 was observed to be 
underexpressed. This was also reported by Chang et al. [70] and they 
associate this alteration in expression to targeting of NFKB1 
promoter by the TAL1 oncoprotein. The underexpression of 
CCND1 and RAC1, which are generally overexpressed in neoplasms, 
in the datasets under study might indicate that these genes were not 
associated with leukemogenesis in the patient samples used for the 
expression study. Although most cancers show high expression levels 
of VEGF, in some cancers such as benign forms of melanoma [71] 
and in cancers with high microsatellite instability [72] lower 
expression of VEGFA are associated with better prognosis. The 
underexpression of VEGFA in the T-ALL datasets examined may 
also be indicative of favorable prognosis in the T-ALL patients. 
Gottardo et al. [73] also reported downregulation of Notch2 in their 
analysis of T-ALL and they associate this lowered expression to 
adverse outcome in the patients. 
Though in majority of the cancers underexpression of tumor 
suppressor SMAD2 has been reported, in a few cancers such as 
Pancreatic cancer and Gastric cancer, an overexpression of this protein 
has been observed [74,75]. Researchers have attributed this increase 
to the shift in TGFβ from tumor suppressor to oncogene in advanced 
metastasis [75]. Shinto et al. [75] have proposed that since this 
protein is involved in activation of SMAD2, an increase in TGFβ 
may lead to a concomitant increase in SMAD2 expression and thus 
contributes to increased cell proliferation through TGFβ receptor 
signaling pathway [75]. This mechanism may also be prevalent in T-
ALL.  
SMAD4 is also a major tumor suppressor which is generally 
downregulated in cancers. Studies have reported SMAD4 
overexpression in Rhabdomyosarcoma cells and suggest that this 
upregulation is through TGFβ1 [76]. A similar mechanism may also 
take place in T-ALL and contribute to TGFβ-mediated aberrant 
proliferation in these cells. 
Thus, this study identified three unreported genes in 
leukemogenesis.                 
 
Conclusion 
 
The Notch intercellular signaling pathway is conserved 
evolutionarily and regulates interactions between adjacent cells. 
Protein interaction studies through network biology help provide an 
insight into possible disease pathways. The interactors associated with 
disease proteins might play key roles in the mechanism of disease and 
hence a study of protein interactions is essential towards 
understanding disease etiology. In our study, we observed that the 
Notch signaling proteins are closely associated functionally with 
proteins that are crucial in cell cycle, cell differentiation and apoptosis 
processes. Our study of the network of Notch1 protein interactors 
has highlighted the possible interactions through which Notch 
signaling might lead to uncontrolled proliferation of cells leading to 
neoplastic transformation resulting in Leukemia. The Notch1 
interaction network shows that the protein interactors of Notch1 play 
an equally crucial and specific role in Notch mediated signaling. 
These interactions could signify that therapeutic approaches 
concentrating on specific Notch mediated targets and proteins that 
associate with Notch and help in its control of cell proliferation, 
might prove as effective targets towards preventing proliferation of 
leukemic cells. We have identified three genes-KAT2B, PSEN1 and 
CDH2- which encode hub proteins and investigating their role in 
leukemogenesis might help in development of new therapeutic 
measures. It is predicted that this study could serve as a repository for 
selection of prognostic and therapeutic moieties involved in Notch 
mediated leukemia. 
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